[Form 4] Haemonetics Corporation Insider Trading Activity

Rhea-AI Filing Summary

Form 144 filed for Arista Networks (ANET) indicates a proposed sale of 162,274 common shares through J.P. Morgan Securities on 07/25/2025. The shares represent a small fraction of the 1,255,921,431 shares outstanding disclosed in the notice and have an aggregate market value of $18.66 million.

The filing also lists extensive selling activity during the prior three months by related parties, largely family trusts and individual holder Jayshree Ullal. Combined, these parties disposed of roughly 961,710 shares of ANET common stock between 06/26/2025 and 06/30/2025, generating gross proceeds that individually ranged from about $20 thousand to $54.2 million per transaction.

Rule 144 filings signal intent rather than a completed trade, yet they often precede actual insider sales. Investors may watch for execution of the planned July sale and evaluate the pattern of recent dispositions when assessing insider sentiment.

Positive

• Transparent disclosure of intended insider sale under Rule 144 gives investors advance notice.
• Limited relative size: the 162,274 shares proposed for sale constitute a small fraction of outstanding shares.

Negative

• Continued insider selling: roughly 961,710 shares were sold in the previous three months by the same related parties.
• Additional supply overhang of $18.66 M may pressure short-term trading dynamics.
• Insider sentiment risk: Concentrated sales by long-tenured holders can be perceived as reduced confidence.

Insights

Securities Analyst

TL;DR: Multiple related parties plan & have recently sold nearly 1 M ANET shares; modest but noteworthy insider supply.

The Form 144 covers 162,274 shares (~$18.7 M) to be sold on 07/25/25. Although this is only a sliver of the reported shares outstanding, the same group—several Ullal family trusts and Jayshree Ullal—has already sold about 962 k shares over the prior quarter. Rule 144 sales are routine for liquidity and diversification, but the volume, timing concentration and involvement of long-time holders raise questions on insider conviction. No operational data accompanies the filing, so fundamental outlook remains unchanged. Nonetheless, incremental supply can weigh on short-term sentiment and is typically viewed as modestly negative for share price momentum.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ABERNATHY ROBERT E

(Last) (First) (Middle)

125 SUMMER STREET

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2025		A		2,693(1)	A	(2)	24,981	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

2. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

	/s/ Thomas V. Powers, attorney-in-fact for Mr. Abernathy	07/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ANET shares are being proposed for sale under this Form 144?

The notice covers 162,274 common shares of Arista Networks to be sold on or about 07/25/2025.

What is the aggregate market value of the proposed ANET share sale?

The filing lists an aggregate market value of approximately $18.66 million for the 162,274 shares.

Who is selling the shares disclosed in the Form 144 for ANET?

The shares are to be sold for the account of parties associated with the Ullal family trusts and Jayshree Ullal, as detailed in the filing.

How much ANET stock have these insiders sold recently?

The same parties sold a combined about 961,710 shares between 06/26/2025 and 06/30/2025, according to the filing.

Does a Form 144 guarantee that the ANET shares will be sold?

No. A Form 144 is a notice of intent; it authorizes—but does not obligate—the insider to complete the sale.